Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [6]
    • NNN Resource Hub
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

A One Health assessment of human–animal interactions, environmental practices, and zoonotic disease knowledge in Bomaa, Ghana

Orish V, Boateng C, Adzah D, et al. Springer Science and Business Media LLC. Discover Public Health. 2026; 23 (1) : 1 - 21.
Download PDF
Publication

Assessing the diagnostic accuracy of the SD-Ov16 rapid diagnostic test compared to the O-150 qPCR for the diagnosis of onchocerciasis in high- and low-endemic settings of Ghana

Nyarko A, Ashong Y, Dogbe S, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2026;
Download PDF
Publication

Burden and Risk Factors of Urinary Schistosomiasis and Bacteriuria Coinfections Among Schoolchildren in an Endemic District in the Ashanti Region, Ghana

Frimpong P, Yar D, Awua-Boateng N, et al. Journal of parasitology research. 2026;
Download PDF
Publication

Economic evaluation of high-dose versus standard-dose rifampicin for the treatment of Buruli Ulcer in Ghana

Novignon J, Okyere E, Gborglah M, et al. African Journal of Current Medical Research. African Journal of Current Medical Research. 2026; 9 (2) : 1.
Download PDF
Publication

Evaluation of the clinical performance of two new onchocerciasis rapid diagnostic tests in districts targeted for elimination in Ghana

de Souza D, Ashong Y, Afatodzie S, et al. Springer Science and Business Media LLC. Scientific Reports. 2026;
Download PDF
Publication

Frequency of Mutations Within P-Glycoprotein and Beta-Tubulin Associated With Ivermectin Treatment in Adult Female Worm Populations in Some Onchocerciasis Endemic Communities in Ghana

Akinkagle R, Opoku M, Afatodzie M, et al. Journal of parasitology research. 2026;
Download PDF
Publication

Integrating neglected tropical diseases into primary healthcare services in Ghana: Results from an initial pilot

Dadzie A, Ananya S, Tougoue J, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2026; 20 (10) : 1 - 15.
Download PDF
Publication

Assessing diagnostic accuracy of onchocerciasis rapid diagnostic tests using Bayesian latent class models

Norman J, Bassabi-Alladjie N, Boko-Collins P, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2026; 20 (10) : 1 - 13.
Download PDF
Publication

High-dose rifampicin and clarithromycin for 4 weeks versus standard-dose rifampicin and clarithromycin for 8 weeks to treat Buruli ulcer: An open-label, individually randomized, controlled trial in Ghana

Agbanyo A, Amoako Y, Opondo C, et al. PLoS neglected tropical diseases. 2026; 20 (9) : 1 - 14.
Download PDF
Publication

Community awareness, symptom recognition, and perceived causes of skin neglected tropical diseases in selected regions of Ghana

Koka E, Adinkra S, Abban A, et al. Frontiers Media SA. Frontiers in Public Health. 2026;
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Ghana

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD